394 related articles for article (PubMed ID: 16412022)
21. Estradiol increases platelet aggregation in Pl(A1/A1) individuals.
Boudoulas KD; Montague CR; Goldschmidt-Clermont PJ; Cooke GE
Am Heart J; 2006 Jul; 152(1):136-9. PubMed ID: 16824843
[TBL] [Abstract][Full Text] [Related]
22. Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin.
Rozalski M; Watala C
Eur J Pharmacol; 2002 Nov; 454(1):1-8. PubMed ID: 12408998
[TBL] [Abstract][Full Text] [Related]
23. [Expression patterns of platelet membrane glycoprotein in healthy adults].
Huang F; Liu R; Liu L
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease.
Burr D; Doss H; Cooke GE; Goldschmidt-Clermont PJ
Stat Med; 2003 May; 22(10):1741-60. PubMed ID: 12720308
[TBL] [Abstract][Full Text] [Related]
25. Platelet glycoprotein polymorphisms: risk, in vivo expression and severity of atherothrombotic stroke in Chinese.
Zhang Y; Wang Y; Wang Y; Cui C; Huang P; Li X; Liu S; Lendon C; Guo N
Clin Chim Acta; 2007 Mar; 378(1-2):99-104. PubMed ID: 17196570
[TBL] [Abstract][Full Text] [Related]
26. Common variations in platelet glycoproteins: pharmacogenomic implications.
Quinn MJ; Topol EJ
Pharmacogenomics; 2001 Nov; 2(4):341-52. PubMed ID: 11722284
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
Leytin V; Shapiro H; Novikov I; Radnay J
Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
[TBL] [Abstract][Full Text] [Related]
28. Relationships of glycoproteins IIb-IIIa and Ib content with mean platelet volume and their genetic polymorphisms.
Khaspekova SG; Zyuryaev IT; Yakushkin VV; Sirotkina OV; Zaytseva NO; Ruda MY; Panteleev MA; Mazurov AV
Blood Coagul Fibrinolysis; 2014 Mar; 25(2):128-34. PubMed ID: 23941967
[TBL] [Abstract][Full Text] [Related]
29. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
30. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
[TBL] [Abstract][Full Text] [Related]
31. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival.
Oksala NK; Heikkinen M; Mikkelsson J; Pohjasvaara T; Kaste M; Erkinjuntti T; Karhunen PJ
Stroke; 2007 Jan; 38(1):50-5. PubMed ID: 17138951
[TBL] [Abstract][Full Text] [Related]
32. Primary thrombophilia in Mexico IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype.
Ruiz-Argüelles GJ; Garcés-Eisele J; Camacho-Alarcón C; Reyes-Nuñez V; Moncada-González B; Valdés-Tapia P; León-Montes N; Ruiz-Delgado GJ
Clin Appl Thromb Hemost; 2013; 19(6):689-92. PubMed ID: 22751911
[TBL] [Abstract][Full Text] [Related]
33. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice.
Di Castelnuovo A; de Gaetano G; Benedetta Donati M; Iacoviello L
Am J Pharmacogenomics; 2005; 5(2):93-9. PubMed ID: 15813672
[TBL] [Abstract][Full Text] [Related]
34. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ
Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the alphaIIb and beta3 genes that cause Glanzmann thrombasthenia can be distinguished by a simple procedure using transformed B-lymphocytes.
Rosenberg N; Dardik R; Rosenthal E; Zivelin A; Seligsohn U
Thromb Haemost; 1998 Feb; 79(2):244-8. PubMed ID: 9493569
[TBL] [Abstract][Full Text] [Related]
36. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.
Shields DC; Fitzgerald AP; O'Neill PA; Muckian C; Kenny D; Moran B; Cannon CP; Byrne CE; Fitzgerald DJ
Pharmacogenomics J; 2002; 2(3):182-90. PubMed ID: 12082590
[TBL] [Abstract][Full Text] [Related]
37. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression.
Block KL; Poncz M
Stem Cells; 1995 Mar; 13(2):135-45. PubMed ID: 7787779
[TBL] [Abstract][Full Text] [Related]
38. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
[TBL] [Abstract][Full Text] [Related]
39. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
40. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
